Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Receivables - Net (2016 - 2020)

Historic Receivables - Net for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q2 2020 value amounting to $5.7 million.

  • Avadel Pharmaceuticals' Receivables - Net fell 4404.25% to $5.7 million in Q2 2020 from the same period last year, while for Jun 2020 it was $5.7 million, marking a year-over-year decrease of 4404.25%. This contributed to the annual value of $8.3 million for FY2019, which is 2691.09% down from last year.
  • According to the latest figures from Q2 2020, Avadel Pharmaceuticals' Receivables - Net is $5.7 million, which was down 4404.25% from $8.8 million recorded in Q1 2020.
  • In the past 5 years, Avadel Pharmaceuticals' Receivables - Net ranged from a high of $24.1 million in Q3 2017 and a low of $4.9 million during Q1 2016
  • In the last 5 years, Avadel Pharmaceuticals' Receivables - Net had a median value of $11.6 million in 2018 and averaged $12.5 million.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Receivables - Net surged by 103477.83% in 2016, and later tumbled by 5961.38% in 2018.
  • Avadel Pharmaceuticals' Receivables - Net (Quarter) stood at $17.8 million in 2016, then fell by 17.12% to $14.8 million in 2017, then fell by 23.37% to $11.3 million in 2018, then fell by 26.91% to $8.3 million in 2019, then crashed by 31.26% to $5.7 million in 2020.
  • Its Receivables - Net was $5.7 million in Q2 2020, compared to $8.8 million in Q1 2020 and $8.3 million in Q4 2019.